Uptake of glucose analogues by colonic tumour cells during growth and after treatment with hydroxyurea

Cancer Lett. 1999 Jul 1;141(1-2):85-91. doi: 10.1016/s0304-3835(99)00075-0.

Abstract

SW620 cells were grown in tissue culture flasks to various cell densities producing populations of cells with a range of proliferative indices. The uptake of the two glucose analogues, deoxy-D-glucose (DG) and 3-O-methylglucose (OMG) was determined and found to be associated with S-phase fraction. The strong correlation between DG and OMG uptakes suggested that proliferation-related changes in transmembrane transport accounted for the association with S-phase fraction. Treatment of SW620 cells with the cell cycle inhibitor hydroxyurea was found to increase the uptake of DG and OMG in a time-dependent manner.

MeSH terms

  • 3-O-Methylglucose / pharmacokinetics*
  • Cell Division / drug effects
  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / pathology
  • DNA / metabolism
  • Deoxyglucose / pharmacokinetics*
  • Flow Cytometry
  • Humans
  • Hydroxyurea / pharmacology*
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • 3-O-Methylglucose
  • DNA
  • Deoxyglucose
  • Hydroxyurea